ALS News Today Home | ALS News Today
WEB5 days ago · RAG-17, an investigational therapy from Ractigen Therapeutics, was safe and well tolerated across all tested doses in people with amyotrophic lateral sclerosis (ALS) carrying mutations in the SOD1 gene — cases in which the disease is known as SOD1-ALS. Those are the findings of an investigator-initiated trial (NCT05903690)….
Types of Amyotrophic Lateral Sclerosis (ALS) – ALS News Today
WEBMar 8, 2023 · Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that can be classified into different types based on factors like genetics, a patient’s family history, and the disorder’s early symptoms. Across all types, ALS is marked by the loss of motor neurons, the nerve cells that control voluntary muscle movements ...
News Archives - ALS News Today
WEBThe U.S. Food and Drug Administration (FDA) has given the green light to Dr.Noah Biotech to initiate a Phase 1 clinical trial of NDC-011, a combination therapy for amyotrophic lateral sclerosis (ALS), in healthy volunteers. The trial, planned for the first half of 2025 at a single site…. September 11, 2024 News by Andrea Lobo, PhD.
Different Stages of ALS Linked to Certain Blood Markers, Study …
WEBApr 1, 2019 · In the recruited group, there were 106 stage 1 patients, 240 stage 2 patients, 131 stage 3 patients, and 37 stage 4 patients. The investigators compared the levels of various molecules in the blood between ALS patients and controls and between patients at different stages of ALS. Most notably, the researchers found that uric acid (an ...
Documentary about I AM ALS seeks to inspire, raise awareness
WEBMay 24, 2024 · A new documentary about I AM ALS and the “revolutionary movement” begun by the organization’s founders — which will stream globally on May 28 — is seeking to advance awareness of amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders while inspiring others to fight for change. Called “ For Love and Life: No ...
ALS News Today Forums
WEBNavigating ALS Challenges. This is a space for discussing daily life and challenges related to ALS. Diagnosis Information and General Questions Mobility Aides, Assistive Technology and Medical Equipment ALS and Relationships. 3 weeks, 6 days ago.
Clinical trial of oral ALS therapy SPG302 is enrolling in...
WEBby Andrea Lobo, PhD July 14, 2023. Spinogenix has launched a clinical trial in Australia to investigate its amyotrophic lateral sclerosis (ALS) treatment candidate SPG302 in patients and healthy volunteers. The first-in-human Phase 1 clinical trial (NCT05882695), which is recruiting up to 112 participants, is being conducted at the Nucleus ...
Amyotrophic Lateral Sclerosis (ALS) Causes | ALS News Today
WEBFeb 2, 2023 · Causes of ALS. The exact cause of amyotrophic lateral sclerosis (ALS) is largely unknown, but a number of factors including genetics, environmental exposures, and lifestyle habits have been linked to an increased risk of ALS. Also known as Lou Gehrig’s disease, named after the famous baseball player who was diagnosed with the …
ALS Facts and Statistics – ALS News Today
WEBThe disease is most common among people 60 years or older, but nearly 10 percent of ALS patients are 45 or younger. Although ALS is 20 percent more likely to develop in men than in women, with advancing age, the gender difference disappears. Moreover, Caucasians and non-Hispanics are more likely to develop ALS compared with other ethnic groups.
Phase 1 clinical trial of experimental ALS therapy AKV9 to soon...
WEBAug 28, 2023 · Akava Therapeutics will soon launch a Phase 1 clinical trial to test AKV9, its investigational therapy for amyotrophic lateral sclerosis (ALS), in healthy people. The trial follows the clearance of Akava’s investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA). It will be AKV9’s first-in-human study and is ...
Skip to content